Gordion Bioscience
Gordion Bioscience is an oncology company focused on developing better drugs by leveraging patient tumor data and machine learning. Their mission is to outsmart cancer by integrating patient selection into the target identification stage. They utilize 100% of genome data, including Exome & Dark Genome alterations, to identify novel drug targets that are 'invisible' in cell line-based assays. Their primary therapeutic strategy is Synthetic Lethality, aiming to target tumors with inactivated suppressor genes and undruggable oncogenes. The company was founded by field-leading academics and brings together expertise in genomics, machine learning, and oncology.
Gordion Bioscience
Gordion Bioscience is an oncology company focused on developing better drugs by leveraging patient tumor data and machine learning. Their mission is to outsmart cancer by integrating patient selection into the target identification stage. They utilize 100% of genome data, including Exome & Dark Genome alterations, to identify novel drug targets that are 'invisible' in cell line-based assays. Their primary therapeutic strategy is Synthetic Lethality, aiming to target tumors with inactivated suppressor genes and undruggable oncogenes. The company was founded by field-leading academics and brings together expertise in genomics, machine learning, and oncology.